Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Huijuan Qin

Huijuan Qin publishes mostly in Molecular Biology, Surgery and Plant Science, on topics such as Plant Molecular Biology Research, Plant Stress Responses and Tolerance and Cancer Genomics and Diagnostics.

OpenAlex
World rank
#4,848,081
of 7,710,434 ranked researchers
Rank in China
#729,777
of 978,568
Works
26
Citations
130
Citations per work
5.0
h-index
6
i10-index 5Top 94% in Molecular Biology
Huijuan Qin

What does Huijuan Qin research?

Huijuan Qin's work is mostly in Medicine (27%), Biochemistry, Genetics and Molecular Biology (18%), Agricultural and Biological Sciences (10%).

Everything else: 12 works · 45.2% of their workLife Sciences: 7 works · 27.4% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 17.8% of their workMolecular Biology: 4 works · 13.7% of their workCancer Research: 1 works · 4.1% of their workAgricultural and Biological Sciences: 2 works · 9.6% of their workPlant Science: 2 works · 9.6% of their workHealth Sciences: 7 works · 27.4% of their workMedicine: 7 works · 27.4% of their workSurgery: 3 works · 11.0% of their workPulmonary and Respiratory Medicine: 2 works · 9.6% of their workOncology: 2 works · 6.8% of their workTHEIR WORKHuijuan Qin26works
Life Sciences27%Health Sciences27%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1245.2%
    1. Biochemistry, Genetics and Molecular Biology517.8%
    2. Agricultural and Biological Sciences29.6%
    1. Medicine727.4%
  1. 1Molecular Biology14% of their works
  2. 2Surgery11% of their works
  3. 3Plant Science10% of their works
  4. 4Pulmonary and Respiratory Medicine10% of their works
  5. 5Oncology7% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Huijuan Qin's research?

The keywords of their largest research topics: Gene Expression, Transcription Factors, Antioxidants, Biliary Tract Cancer, Bronchopulmonary Dysplasia, Cancer Genomics, Cholangiocarcinoma and Development.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Gene Expression62 topics
  2. Transcription Factors52 topics
  3. Antioxidants31 topic
  4. Biliary Tract Cancer31 topic
  5. Bronchopulmonary Dysplasia31 topic
  6. Cancer Genomics31 topic
  7. Cholangiocarcinoma31 topic
  8. Development31 topic
  9. Mutational Signatures31 topic
  10. Plant31 topic
  11. Preterm Infants31 topic
  12. Reactive Oxygen Species31 topic
  13. Adenosine Receptors21 topic
  14. Flavonoid Biosynthesis21 topic
  15. MYB21 topic
  16. Purinergic Signalling21 topic
  17. RNA methylation21 topic
  18. m6A-seq21 topic

Where does Huijuan Qin work?

Huijuan Qin's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Huijuan Qin have?

OpenAlex counts 26 works and 130 citations for Huijuan Qin, an h-index of 6, ranking #4,848,081 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Huijuan Qin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.